Insights

Benchmark International Successfully Facilitated the Transaction Between Webmed Pharmacy Ltd and Vulcan Two Group plc

April 1, 2026

Benchmark International is delighted to announce the acquisition of Webmed Pharmacy by Vulcan Two.

Webmed is a vertically integrated B2C digital pharmacy, dispensing and distributing medications through a bespoke consumer-facing eCommerce website. Based in Cheshire, England, Webmed was founded in 2014 to address the need for discrete treatment and testing for sensitive and intimate conditions. The business offers a wide variety of treatments for conditions such as weight-loss, sexually transmitted infections, erectile dysfunction and hair loss. Webmed has shown robust and profitable growth in recent years.

Vulcan Two is aiming to create the UK's leading regulated ePharmacy platform through buy-and-build. As well as Webmed Pharmacy, Vulcan Two has also acquired CloudRx Holdings Limited and Hyperdrug Pharmaceuticals Ltd for an aggregate consideration of up to £41.7 million. The transaction constituted a reverse takeover under the AIM Rules.

 Discover what your business could be worth in today’s market. 

The directors believe that the growth of the enlarged group will be supported by strong market tailwinds and driven by targeted sales initiatives, scalable infrastructure and a drive to best-in-class service. It is expected to show underlying profitability and cash generation, generating over £35 million revenue, with a high proportion of recurring revenues.

Michael Kraftman, Chief Executive Officer of Vulcan Two, commented:

"We are delighted to announce the acquisitions which will serve as the foundation on which we will aim to build the UK's leading regulated ePharmacy platform. This significant milestone marks the beginning of an exciting new chapter as we work to integrate the targets and pursue our strategy as stated at IPO, supported by strong market tailwinds. We believe we are well positioned for the future, and look forward with great excitement to further opportunities ahead."

Schedule a Call

Americas: Sam Smoot at +1 (813) 898 2350 / [email protected]

Europe: Michael Lawrie at +44 (0) 161 359 4400 / [email protected]

Africa: Anthony McCardle at +27 21 300 2055 / [email protected] 

 

ABOUT BENCHMARK INTERNATIONAL:

Benchmark International is a global M&A firm that provides business owners with creative, value-maximizing solutions for growing and exiting their businesses. Benchmark International has handled transactions across various industries from offices across the world. With decades of M&A experience, Benchmark International’s transaction teams have assisted business owners with achieving their objectives and ensuring the continued growth of their businesses. The firm has also been named the Investment Banking Firm of the Year by The M&A Advisor and the Global M&A Network, as well as the #1 Sell-side Privately Owned M&A Advisor in the World by PitchBook’s and LSEG's Global League Tables.

The content provided by Benchmark International, including articles, blog posts, videos, and other media, is for general informational purposes only and does not constitute legal, financial, investment, or business advice. While we strive for accuracy, the information may be based on third-party sources, market trends, and evolving industry data that are not independently verified or guaranteed to be current or complete. Any opinions expressed are those of the authors and do not necessarily reflect the views of Benchmark International. Market trends, forecasts, and forward-looking statements are inherently uncertain and subject to change. Nothing in our content should be relied upon as a substitute for personalized advice from qualified professionals. Benchmark International disclaims all liability for any loss or damage resulting from reliance on this content. Always consult with appropriate experts before making business decisions.

Share This Post
Categories

Get These Insights Delivered Directly To Your Email

Explore our curated collection today and stay ahead of the curve in M&A.

Related Posts
Tax Risks in M&A TransactionsRecent studies indicate that the most common claims buyers make against sellers for violations of sellers' representations and warranties in M&A purchase agreements relate to tax matters. In reality, there is never just a buyer and a seller in an M&A transaction. Both sides share a silent partner, the taxman. Actually, they both have a "taxman" because Uncle Sam is not the only "silent partner" owed a cut of the target company's profits. State and local authorities, often multiple of each, have a seat at that table. Trailing Twelve Months Financials: Why They Matter in M&ABusiness owners often assume that strong historical performance alone will be sufficient. While past results are important, buyers focus more on recent performance when evaluating an acquisition target. Annual financial statements and year-to-date results can be incomplete or misleading depending on timing and seasonality. A trailing twelve-month (TTM) period bridges this gap by providing a current, normalized view of a company’s financial performance.
Not Finding What You're Looking For?
Ready to dive into our featured M&A content and gain valuable insights for your business?